Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle

Journal of Cellular Physiology

Volumn 154, Issue 1, 1993, Pages 7-15

  Terada, Naohiro ^a   Lucas, Joseph J ^a   Szepesi, Agota ^a   Franklin, Richard A ^a   Domenico, Joanne ^a   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR; RAPAMYCIN;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

BASE SEQUENCE; CELL CYCLE; DNA, SINGLE-STRANDED; G1 PHASE; HUMAN; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; POLYENES; SIROLIMUS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0027510985     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.1041540103     Document Type: Article

References (41)

1. Complete nucleotide sequence of the chromosomal gene for human IL‐4 and its expression
2. The retinoblastoma protein copurifies with E2F‐1, and E1A‐regulated inhibitor of the transcription factor E2F
3. Cyclin A and the retinoblastoma gene product complex with a common transcription factor
4. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle
5. The E2F transcription factor is a cellular target for the RB protein
6. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation
7. The T/E1A‐binding domain of the retinoblastoma product can interact selectively with a sequence‐specific DNA‐binding protein
8. Contingent genetic regulatory events in T lymphocyte activation
9. Lymphocyte stimulation: A rapid multiparameter analysis
10. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element
11. Activation of cdc2 protein kinase during mitosis in human cells: Cell cycle‐dependent phosphorylation and subunit rearrangement
12. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK‐506 and rapamycin
13. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation
14. 1 to S transition in human T lymphocytes
15. A 60 kd cdc2‐associated polypeptide complexes with the E1A proteins in adenovirus‐infected cells
16. The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter
17. New views of the biochemistry of eucaryotic DNA replication revealed by aphidicolin, an unusual inhibitor of DNA polymerase α
18. Inhibition of T and B lymphocyte proliferation by rapamycin
19. Induction of competence and progression signals in human T lymphocytes by phorbol esters and calcium ionophores
20. Cyclosporin A inhibits initiation but not progression of human T cell proliferation triggered by phorbol esters and calcium ionophores
21. A monoclonal antibody that appears to recognize the receptor for human T cell growth factor: Partial characterization of the receptor
22. FK‐506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes
23. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase
24. Calcineurin is a common target of cyclophilincyclosporin A and FKBP‐FK506 complexes
25. Rb phosphorylation during progression of normal human T cells
26. c‐fos protein can induce cellular transformation: A novel mechanism of activation of a cellular oncogene
27. Reversible tyrosine phosphorylation of cdc2: Desphosphorylation accompanies activation during entrance into mitosis
28. Rapamycin: FK506′s fraternal twin or distant cousin?
29. Molecular structure of the human cytoplasmic β‐actin gene: Interspecies homology of sequences in the introns
30. Human cyclin A is adenovirus E1A‐associated protein p60 and behaves differently from cyclin B
31. cdc2: The S and M kinase
32. Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte‐specific factors to the IL‐2 enhancer
33. Negative regulation of human c‐fos expression by the retinoblastoma gene product
34. Chemistry and biology of the immunophilins and their immunosuppressive ligands
35. Structure and expression of a cloned cDNA for human interleukin‐2
36. In vitro phosphorylation of the tumour suppressor gene Rb protein by mitosis‐specific histone H1 kinase
37. Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells. 1991
38. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes
39. Severe combined immune deficiency due to a specific defect in interleukin‐2 production
40. Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen‐induced cytokine production and lymphoproliferation
41. The retinoblastoma susceptibility gene product: A characteristic pattern in normal cells and abnormal expression in malignant cells